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Although several interleukin-17 (IL-17) family
members and their receptors have been recently
appreciated as important regulators in inflammatory
diseases, the function of other IL-17 cytokines and
IL-17 receptor-like molecules is unclear. Here we
show that an IL-17 cytokine family member, IL-17C,
was induced in a Th17 cell-dependent autoimmune
disease and was required for its pathogenesis.
IL-17C bound to IL-17RE, amember of IL-17 receptor
family whose full-length isoform was selectively ex-
pressed in Th17 cells and signaled via an IL-17RA-
RE receptor complex and the downstream adaptor
Act1. IL-17C-IL-17RE induced the expression of a
nuclear IkappaB family member, IkBz, in Th17 cells
to potentiate the Th17 cell response. Thus, our work
has identified a cytokine-receptor pair with important
function in regulating proinflammatory responses.
This pathway may be targeted to treat autoimmune
diseases.INTRODUCTION
Interleukin-17 (IL-17) family cytokines have recently emerged as
important players in inflammatory responses. IL-17A and IL-17F,
which are most highly related among IL-17 family cytokines, are
expressed by a distinct T cell subset, Th17 cells (Dong, 2008).
The cytokines TGF-b and IL-6 or IL-21 have been shown to be
critical in generation of Th17 cells (Bettelli et al., 2006; Korn
et al., 2007; Mangan et al., 2006; Nurieva et al., 2007; Veldhoen
et al., 2006), leading to the expression of lineage-specific tran-
scription factors, RORgt (Ivanov et al., 2006) and RORa (Yang
et al., 2008c). RORgt and RORa are retinoic-acid-receptor-
related orphan receptors that are induced by activation of the
STAT3 pathway by IL-6 (Yang et al., 2007). Other transcription
factors are also reported to promote Th17 cell differentiation.
Most recently, IkBz, a nuclear IkappaB familymember, was iden-
tified to be induced by STAT3 and promote Th17 cell differenti-
ation by cooperating with RORgt and RORa (Okamoto et al.,
2010). Th17 cells also express IL-1R and IL-23R, rendering the
cells to selectively respond to IL-1 (Chung et al., 2009) andIL-23 (Langrish et al., 2005) for their differentiation and cytokine
expression.
Th17 cells, via production of IL-17A and IL-17F, promote the
development of autoimmune diseases while protecting the
host against bacterial and fungal infections (Kolls and Linde´n,
2004). IL-17A and IL-17F signal through the IL-17 receptor A
(IL-17RA)-IL-17RC complex (Hu et al., 2010; Toy et al., 2006).
Although IL-17RA is expressed ubiquitously, IL-17RC expres-
sion is dominant in nonhematopoietic cells (Kuestner et al.,
2007). IL-17A and IL-17F target epithelial cells or fibroblasts to
produce arrays of cytokines and chemokines including IL-6
and CXCL1 (Chang and Dong, 2009; Gaffen, 2008). A distant
member of IL-17 family cytokine, IL-25 (IL-17E), is involved in
allergic diseases and host defense against parasitic helminthes
(Chang and Dong, 2009; Kolls and Linde´n, 2004; Pappu et al.,
2008). Recently, it was shown that IL-25 utilized IL-17RA and
IL-17RB as a receptor complex (Angkasekwinai et al., 2010;
Rickel et al., 2008). IL-17RB is expressed in Th2 (Angkasekwinai
et al., 2007; Wang et al., 2007) and Th9 (Angkasekwinai et al.,
2010) cells as well as a subset of NKT cells (Terashima et al.,
2008). IL-25 induces the production of IL-4, IL-5, IL-13, and
IL-9 in these target cell types. IL-17RA, IL-17RC, and IL-17RB
recruit Act1 (Chang et al., 2006; Claudio et al., 2009; Qian
et al., 2007), an intracellular adaptor molecule sharing homology
with the cytoplasmic domain of the IL-17R family (Novatchkova
et al., 2003), to mediate downstream signaling.
Although IL-17 family members IL-17A, IL-17F, and IL-25 (as
well as IL-17 receptor family members IL-17RA, IL-17RC, and
IL-17RB) have been relatively well studied in immune responses
and inflammatory diseases, the function of other IL-17 family
cytokines and IL-17R-likemolecules is unclear. IL-17Cwas iden-
tified along with IL-17B by a homology search of IL-17-like cyto-
kines and reported to stimulate THP, a monocytic cell line, to
produce TNF-a and IL-1b (Yamaguchi et al., 2007). Adenoviral
delivery of IL-17C to lung triggers neutrophil recruitment (Hurst
et al., 2002). IL-17C-overexpressing CD4+ T cells exacerbate
collagen-induced arthritis in recipient mice (Yamaguchi et al.,
2007). These results suggest that IL-17C may have an important
proinflammatory function.
IL-17RE belongs to the IL-17R family and was originally iden-
tified based on searches for IL-17R homologous sequences
(Li et al., 2006). The closest related molecule of IL-17RE is
IL-17RC. IL-17RE shares 18% of amino acid sequence identity
with IL-17RC and the two genes encoding these receptors are
located adjacent to each other on human chromosome 3 andImmunity 35, 611–621, October 28, 2011 ª2011 Elsevier Inc. 611
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carrying a single transmembrane domain with various short iso-
forms ranging from 34 to 70 kD. However, little is known on the
specific ligands and signaling functions of these proteins. It
was previously reported that IL-17RE has mitogenic activity in
a ligand-independent manner (Li et al., 2006). A recent
genome-wide association study revealed that IL17REL, a close
homolog of IL17RE, is a risk locus for ulcerative colitis (Franke
et al., 2010).
In this study, we have studied the function of IL-17C and iden-
tified IL-17RE as its receptor in regulation of Th17 cell differenti-
ation and autoimmune diseases. IL-17C-IL-17RE signaling may
be a promising target in the treatment of chronic autoimmune
diseases.
RESULTS
IL-17C Is Necessary for Pathogenesis of EAE
As a first step to understand the function of IL-17C, we gener-
ated Il17c/ mice by gene targeting. A LacZ-coding sequence
was inserted into exon 2 to disrupt the expression of Il17c (see
Figures S1A and S1B available online). These mice developed
normally and did not exhibit any pronounced immunological
deficiency. Normal development of lymphocytes was observed:
CD4+ and CD8+ T cells in spleen and draining lymph nodes are
comparable between WT (wild-type) and Il17c/ mice (Fig-
ure S1C). Also, the number of regulatory T cells in Il17c/
mice was similar to that in WT mice (Figure S1C). When spleno-
cytes were restimulated with PMA plus ionomycin, the amount of
IL-17A and IFN-g production was comparable between Il17c/
and WT CD4+ and CD8+ T cells (Figure S1D).
To explore the role of IL-17C in inflammatory diseases, we
analyzed IL-17C expression in different tissues and found that
its expression was increased by approximately 15-fold in the
central nervous system (CNS) of mice induced with experimental
autoimmune encephalomyelitis (EAE) compared to the normal
CNS. This result suggests a role of this cytokine in autoimmune
diseases. To examine whether IL-17C is involved in the develop-
ment of autoimmune diseases, EAE was therefore induced
in Il17c/ mice along with appropriate WT controls. Il17c/
mice exhibited a decrease in EAE severity, with substantial
differences observed in peak clinical scores of all mice as well
as peak score of those exhibiting clinical symptoms, though
the kinetics of EAE onset did not appear to have been affected
between the two groups (Figure 1A; Table 1). Additionally, only
50% of Il17c/ mice exhibited EAE symptoms compared to
100% of the WT mice (Figure 1A).
To analyze whether the protection by Il17c/ mice against
EAE development and severity was related to CD4+ T effector
cell function, we next analyzed cell infiltration and cytokine
expression in total CNS tissue in EAE mice. In the CNS, the
numbers of CD4+ T cells were higher in WT mice than in Il17c/
mice, whereas the numbers of CD11b+ macrophages were
comparable between the two groups (Figure 1B). Moreover,
WT CD4+ T cells in CNS contained higher numbers of IL-17A+,
IFN-g+, and IL-17A+IFN-g+ producers compared to CD4+
T cells derived from Il17c/ animals (Figures 1B). The per-
centage of IFN-g+ cells was higher in WT compared with the
Il17c/ CD4+ T cell population whereas the percentages of612 Immunity 35, 611–621, October 28, 2011 ª2011 Elsevier Inc.IL-17A+ or IL-17A+IFN-g+ cells were not different (Figures 1B
and 1C). We then directly examined cytokines and chemokines
expressed at the sites of inflammation. IL-17C deficiency re-
sulted in significant decreases in the Th17 cell-related mediators
Il17a, Il17f, Il22, Ccr6, andCcl20 (p < 0.05) (Figures 1D). Interest-
ingly, we also observed a noticeable decrease in Ifng mRNA
expression in the CNS of Il17c/ mice. In addition to the CNS,
splenocytes from EAE mice were restimulated with MOG35-55
peptide to analyze cytokine expression. WT and Il17c/ CD4+
T cells were found to proliferate similarly (data not shown) and
the cytokine response to MOG35-55 peptide was similar between
WT and Il17c/ mice by intracellular cytokine staining (Fig-
ure 1E). Thus, IL-17C appears to be necessary for the pathogen-
esis of EAE disease and for CNS inflammation in this model.
IL-17C Binds to IL-17RE
To identify the mechanism whereby IL-17C mediates proinflam-
matory function in EAE disease, we first searched for the
receptor of IL-17C among IL-17R family members and the target
cells for IL-17C. 293T cells were transfected with various IL-17R
family members, and an IL-17C-hIg fusion protein we generated
was used to detect the binding. Compared to cells transfected
with an empty vector, substantial increases in binding of IL-
17C-hIg was observed in 293T cells transfected with IL-17RE
(Figure 2A). We did not detect any measurable binding of
IL-17C-hIg to IL-17RA or other members of the IL-17 receptor
family by the same system (Figure 2B). Expression of IL-17
receptor molecules was confirmed in this system via binding of
positive control IL-17 cytokine fusion proteins and through
real-time RT-PCR (Figure S2).
IL-17RE Is Highly Expressed in Th17 Cells
To understand how IL-17C-IL-17RE regulates pathogenesis of
autoimmune disease, we further examined the expression of
Il17re mRNA by RT-PCR. Based on the previous literature (Li
et al., 2006), IL-17RE is predicted to have multiple isoforms.
Il17re mRNA was detected in various cell types by RT-PCR but
they mostly expressed an isoform lacking the transmembrane
domain (data not shown). Interestingly, in our previous microar-
ray analysis of different T cell subsets (Nurieva et al., 2008), we
found Il17re mRNA to be upregulated in Th17 cells (data not
shown). To further confirm this result, we isolated naive or natural
regulatory T cells and prepared in vitro differentiated Th1, Th2,
Th17, and inducible regulatory T cells (Figure S3). Among these
subsets of CD4+ T cells, Th17 cells expressed the highest
amount of full-length Il17re mRNA (Figure 3A). Because the
development of Th17 cells requires transcription factors
STAT3, RORg, and RORa, we then asked whether expression
of Il17re is dependent on these factors. Naive CD4+ T cells
from Stat3/, Rorc/, and Rorasg/sg (Yang et al., 2007,
2008c) cultured in Th17 cell conditions expressed greatly
reduced amounts of Il17re mRNA compared to their WT con-
trols, indicating that they are necessary for Il17re expression
(Figure 3B). Il17re was detected not only in in vitro cultured
Th17 cells but also in in vivo derived Th17 cells. When IL-17F
reporter mice, IL-17FRFP (Yang et al., 2008b), were induced
with EAE, IL-17FRFP+CD4+ T cells isolated from spleen and
CNS tissue expressed higher amounts of Il17re compared to
that from IL-17FRFPCD4+ T cells (data not shown). To identify
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Figure 1. IL-17C Is Necessary for Full Development
of EAE
(A) EAE was induced in WT and Il17c/ animals. Bottom
graph y axis indicates ratios of animals developing EAE.
Data are representative of four independent experiments.
*p < 0.05 (Student’s t test).
(B) Total infiltrating CNS cell counts and percentages of
infiltrating CD4+, CD11b+, IL-17A+, and IFN-g+ cells.
(C) Representative CNS intracellular cytokine staining of
WT and Il17c/ mice after 5 hr PMA plus ionomycin re-
stimulation.
(D) mRNA was analyzed in the CNS tissues of three indi-
vidual mice per group on day 14 after EAE initiation by real-
time RT-PCR. Gene expression data were normalized to
actin (Actb).
(E) Splenic intracellular cytokine staining. Splenocytes
derived from each group were restimulated with or without
MOG35-55 peptide and intracellular cytokine staining was
conducted and analyzed in CD4+ gate.
See also Figure S1.
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IL-17C and IL-17RE in Th17 Cell Regulationwhat cytokine directs the expression of Il17re, we activated
sorted naive CD4+ T cells in the presence of different cytokines.
IL-6 and TGF-b synergistically regulate the expression of Il17re
mRNA and IL-1 and IL-23 further enhanced this expression (Fig-
ure 3C). Expression of a full-length Il17re mRNA was also
confirmed by RT-PCR in T cells treated with TGF-b and IL-6
(Figure 3D).
IL-17C-IL-17RE Regulates Th17 Cell Differentiation
Because full-length Il17re expression is selectively induced in
Th17 cells, we asked whether it has any effect on the differenti-
ation of Th17 cells. Th17 cells transduced with a retroviral vector
encoding full-length IL-17RE but did not show enhanced IL-17A
production compared to the control vector-infected cells (Fig-
ure 4A), suggesting that the ligand for this receptor may be
absent in the culture. We therefore treated cells infected with
retroviruses with different IL-17 cytokine family members and
observed an enhanced production of IL-17A by intracellular
cytokine staining when, and only when, the cells were cultured
with IL-17C (Figure 4B). Moreover, we investigated whetherImmunity 35, 61IL-17C plays any direct role in Th1 cells. IL-17C
did not regulate expression of IFN-g in Th1 cells
with or without IL-17RE overexpression (data
not shown). Interestingly, Th17 cells cultured
with IL-17C exhibited greater expression of
Il17re mRNA compared to those without, sug-
gesting that IL-17C may regulate IL-17RE
expression (Figure S4A).
Our above results suggest that IL-17RE is
a receptor for IL-17C but did not answer whether
there could be another receptor although
binding of IL-17C was restricted to IL-17RE
in vitro. We therefore overexpressed various
members of the IL-17 receptor family (IL-17RA
through IL-17RD) in developing Th17 cells by
retroviral infection and examined the effect
of IL-17C in the induction of IL-17A. IL-17C
enhanced IL-17A production in Th17 cells retro-virally transduced only with IL-17RE, not with other IL-17
receptor family members (Figure 4C). This observation further
supports the principle that IL-17C signals via IL-17RE in Th17
cells.
In support of the above conclusion, we investigated whether
IL-17C-hIg fusion protein associates with Th17 cells in vivo.
Mononuclear cells from CNS of EAE mice were separated by
percoll and stimulated with PMA and ionomycin. 50%–70% of
IL-17A-positive cells from the CNS were CD4+ T cells and this
population stained positively with IL-17C-hIg fusion protein (Fig-
ure S4B). We also found that non-CD4+ T cells, which produce
IL-17A in the CNS, are positively stained with IL-17C-hIg fusion
protein although the staining intensity is weaker than that of
CD4+ T cells. gd T cells are known to produce IL-17A in the
CNS during EAE development (Sutton et al., 2009). When we
analyzed Il17re expression from gd T cells, we found that gd
T cells express higher amounts of Il17re than naive T cells.
Furthermore, sorted IL-17FRFP+ gd T cells express higher
amounts of Il17re in comparison to IL-17FRFP gd T cells, indi-
cating that IL-17A- or IL-17F-producing gd cells also express1–621, October 28, 2011 ª2011 Elsevier Inc. 613
Table 1. MOG35-55 Induced EAE in Il17c
–/– Mice
Group n
Day of Onset
(mean ± SD)
Peak Clinical
Score
(mean ± SD)
Peak Clinical Score
of Symptomatic
Mice (mean ± SD)
WT 16 8.44 ± 2.28 3.50 ± 1.211 3.50 ± 1.211
Il17c/ 15 9.15 ± 3.05 1.833 ± 1.305* 2.292 ± 1.010**
EAE was induced in WT (C57BL/6 and C57BL/6 3 129 mixed) and
Il17c/ (C57BL/6 and C57BL/63 129mixed backgrounds) byMOG35-55
peptide immunization. Student’s t tests were performed to compare peak
clinical score of all mice in each experiment and also of only those that
showed clinical symptoms of EAE. *p = 0.0009; **p = 0.0095. Data are
a compilation of four independent experiments.
A
B
Figure 2. IL-17C Binds to IL-17RE In Vitro
(A) Binding of IL-17C-Ig to IL-17RE. 293T cells were transfected with empty
or IL-17RE expression vector (pcDNA3) and subsequently stained with IL-
17C-hIg, followed by anti-hIg APC.
(B) IL-17C-hIg binds to IL-17RE but not to other IL-17R family. 293T cells were
transfected with empty or IL-17R family expression vector (pcDNA3). Staining
with IL-17C-hIg was performed same as (A).
See also Figure S2.
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IL-17C and IL-17RE in Th17 Cell RegulationIL-17RE. However, when we treated isolated gd T cells with IL-
17C, we did not observe any difference in cytokine production
by intracellular cytokine staining, although IL-23 was able to
induce IL-17A expression from gd T cells (data not shown).
Taken together, these results indicate that IL-17C signals via
IL-17RE in Th17 cells.
IL-17RE and IL-17RA Form a Signaling Complex
for IL-17C and Employ Act1 Adaptor Protein
Because IL-17RA forms a complex with IL-17RC for IL-17A and
IL-17F signaling (Toy et al., 2006) and with IL-17RB for IL-25
signaling (Rickel et al., 2008), we asked whether IL-17RA is
required for the activity of IL-17C and IL-17RE. When naive
T cells from WT and Il17ra/ mice were transduced with an
IL-17RE retroviral vector and differentiated into Th17 cells, the
effect of IL-17C in inducing IL-17A was severely impaired in
Il17ra/ cells (Figure 4F). This observation prompted us to
examine the physical interaction between IL-17RA and IL-
17RE. When IL-17RA- and hemagglutinin (HA)-tagged IL-17RE
were expressed simultaneously in 293T cells, IL-17RA coimmu-
noprecipitated with IL-17RE, suggesting the association of IL-
17RA and IL-17RE as a signaling complex for IL-17C (Figure 4E).
IL-17RA recruits a membrane proximal adaptor protein, Act1,
to mediate IL-17A, IL-17F, and IL-25 signaling (Chang et al.,
2006; Claudio et al., 2009; Qian et al., 2007). In addition, IL-
17RE also bears the SEFIR (similar expression to fibroblast
growth factor genes and IL-17Rs) motif (Novatchkova et al.,
2003), which may interact with Act1 via a homotypic interaction.
Therefore, we tested whether Act1 is required for IL-17C-IL-
17RE signaling with an Act1/ mouse. Upon the addition of
IL-17C in Th17 cell-polarizing conditions, IL-17RE-overexpress-
ing Th17 cells express higher amounts of IL-17A than cells with
vector alone. This effect, however, is abrogated in Act1/
Th17 cells (Figure 4F). Act1/ CD4+ T cells undergo normal
Th17 cell development without IL-17C, suggesting no intrinsic
defect in these cells (Figure 4F). Therefore, we concluded that
Act1 is necessary for IL-17C-IL-17RE signaling.
IL-17C-IL-17RE Regulates IkBz Expression
To further understand the mechanism whereby IL-17C and IL-
17RE enhance Th17 cell differentiation, we further examined
cytokine production and gene expression profiles of IL-17RE-
transduced T cells. After T cells were retrovirally transduced
with IL-17RE or empty expression vector and cultured with
TGF-b and IL-6 in the presence or absence of IL-17C for614 Immunity 35, 611–621, October 28, 2011 ª2011 Elsevier Inc.2 days, we sorted out infected cells and stimulated them with
anti-CD3 for assessment of cytokine production by ELISA and
gene expression profiles by real-time RT-PCR. T cells trans-
duced with IL-17RE and cultured in the presence of IL-17C
expressed higher amounts of not only IL-17A but also IL-17F
and IL-22 (Figures 5A and 5B). However, the expression of
Rora, Rorc, and Il23r remained similar in IL-17RE-overexpress-
ing T cells with or without IL-17C treatment (Figure 5B).
Because IL-17C seems to employ IL-17RA for its signaling,
we tested whether the transcription factors that are induced by
IL-17RA-dependent IL-17A or IL-17F stimulation, C/EBPb,
C/EBPd, and IkBz (encoded by the Nfkbiz gene) (Shen et al.,
2005; Yang et al., 2008a), could be induced by IL-17C. Although
the expression of Cebpb and Cebpd remained unchanged
(Figure S5), Nfkbiz expression was increased in cells treated
with IL-17C, even when T cells were activated under neutral
conditions and Th17 cell differentiation did not occur (Figure 5C),
suggesting that IkBz is a direct target of IL-17RE signaling.
Similar to a recent report (Okamoto et al., 2010), when we
transduced T cells with a retroviral vector expressing IkBz and
cultured these cells in Th17 cell conditions, we found that
IkBz-overexpressing Th17 cells produced enhanced expression
of IL-17A compared to controls (Figure 5E). Also, they expressed
higher amounts of mRNA for Il17a and Il17f while expressing
similar amounts of Rora, Rorc, and Il23r compared to control
cells (Figure 5D). Therefore, IkBz may be a downstream tran-
scription factor in Th17 cells induced by IL-17C and IL-17RE.
Because IkBz has been recently shown to be important in
Th17 cell differentiation and autoimmune disease, our study
identifies a physiological regulator of its expression.
Enhanced IL-17RE Signaling In Vivo Leads to Greater
Susceptibility to EAE
To confirm our in vitro data and further demonstrate the function
of IL-17RE in T cells in vivo, we generated transgenic IL-17RE
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Figure 3. IL-17RE IsHighly Expressed in Th17Cells
(A) Real-time RT-PCR of Il17remRNA expression in sorted
naive, nTreg, and activated CD4+ T cells differentiated
under Th1, Th2, Th17, and iTreg cell conditions. Fold
induction was calculated with naive cells as control and
normalizing to b-actin (Actb) expression. The data are
expressed as the mean ± SD of triplicate samples.
(B) Real-time RT-PCR analysis of Il17re expression in
CD4+ T cells from WT, Stat3/, Rorc/, and Rorasg/sg
mice. Naive CD4+ T cells from each strain were differen-
tiated under Th17 cell conditions for 4 days.
(C) Real-time RT-PCR analysis of Il17remRNA expression
in T cells activated with the indicated cytokines for 4 days.
(D) RT-PCR analysis of Il17re in T cells activated with the
indicated cytokines. The PCR products are amplified with
forward primer before the transmembrane domain and
reverse primer at the end of the coding sequence.
Data shown are representative of at least three indepen-
dent experiments. See also Figure S3.
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IL-17C and IL-17RE in Th17 Cell Regulationmice by using the CD4 minigene. Insertion of a full-length cDNA
into this transgenic cassette that contains the CD4 promoter,
enhancer, and first intron without the silencer results in trans-
gene expression in all T cells (Sawada et al., 1994, Angkasekwi-
nai et al., 2010). Of four founder lines, three were transmitted to
progeny. We compared the expression of Il17re mRNA in naive
CD4+ T cells from these transgenic mice to that in their control
littermates (Figure 6A). Lines 1 and 4, expressing enhanced
amounts of Il17remRNA, were selected for further characteriza-
tion. The CD4-IL-17RE transgenic mice showed normal popula-
tions of T and B cells in lymphoid organs (data not shown). When
naive CD4+ T cells were isolated and cultured in Th17 cell polar-
izing condition in the presence of IL-17C, CD4+ T cells from
IL-17RE transgenic mice produced enhanced amounts of
IL-17A (Figure 6B).
We next analyzed CD4-IL-17RE transgenic mice with an EAE
model. CD4-IL-17RE transgenic or control littermate mice were
immunized with MOG35-55 to induce EAE. When we reduced
the concentration of complete Freund’s adjuvant (CFA) from 5
to 3 mg/ml during the second MOG immunization so that WT
mice did not develop robust EAE, CD4-IL-17RE transgenic
mice exhibited amoderate increase inEAE symptoms (Figure 6C)
associated with an increase in total numbers of infiltrated
mononuclear cells in CNS (Figure 6D). At the peak of disease,
infiltrated leukocytes in CNS were isolated and subjected to
RT-PCR analysis. Whereas other Th17 cell transcription factors
remain similar between two groups of animals (data not shown),
we observed about 2-fold induction of Nfkbiz in CNS-infiltrating
cells in CD4-IL-17RE transgenic mice compared to littermate
mice (Figure 6E). In these EAE mice, MOG35-55-specific Th17
cytokine expression was moderately increased in transgenic
mice although proliferation and IL-2 and IFN-g production re-
mained similar between two groups (Figure 6F). Therefore,
enhanced signaling of IL-17RE in CD4+ T cells leads to greater
EAE disease as well as enhanced Th17 cell response and
increased expression of IkBz.IL-17C-IL-17RE Enhanced Cytokine Expression
by Effector Th17 Cells
Because IL-17RE was induced after the differentiation of Th17
cells and IL-17C expression was detected in inflamed tissues
such as CNS in EAE, we investigated whether IL-17C has any
role to promote Th17 cytokine production in effector Th17 cells.
To this end, naive CD4+ T cells from IL-17FRFP mice (Yang
et al., 2008b) were differentiated with TGF-b and IL-6. At day 5,
RFP-positive cells were sorted (Figure 7A) and cultured in the
presence of increasing amounts of anti-CD3 for 3 days.
Increased production of IL-17A was observed when IL-17C
was added into the culture where anti-CD3 concentration was
between 0.06 and 0.25 mg/ml (Figure 7B), suggesting that
IL-17C synergizes with TCR signaling to potentiate IL-17A
production. In a different setting, polarized Th17 cells were
cultured in the presence of irradiated splenocytes. Similarly,
we observed enhanced IL-17A and IL-17F production from the
effector Th17 cells in an IL-17C concentration-dependent
manner (Figure 7C). Therefore, IL-17C enhances Th17 cytokine
production in effector Th17 cells. Interestingly, we found that
expression of Il17c is much more robustly induced in inflamed
CNS lesions compared to the T cell priming site spleen from
EAE mice (Figure 7D). Therefore, it is likely that the effector
Th17 cells migrate to CNS and upon the encounter with IL-17C
in local tissues, Th17 cells secrete enhanced amounts of effector
cytokines.
DISCUSSION
In the current study, we have found that a cytokine-cytokine
receptor pair, IL-17C and IL-17RE, regulates inflammatory
disease and promotes Th17 cell differentiation (via signaling
components IL-17RA and Act1) and induction of IkBz.
Since the discovery of the cytokine IL-17A and its receptor, IL-
17RA, many molecules that bear homology to IL-17A and IL-
17RA have been reported. Now, the IL-17 cytokine family isImmunity 35, 611–621, October 28, 2011 ª2011 Elsevier Inc. 615
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Figure 4. IL-17C-IL-17RE Regulates Th17 Cell
Differentiation
(A) Intracellular cytokine staining of IL-17A and IFN-g. After
naive CD4+ T cells were retrovirally transduced with
control viral vector or IL-17RE, different IL-17 family
cytokines were added during Th17 cell differentiation. The
cells were restimulated with PMA and ionomycin for
cytokine staining.
(B) Statistical analysis of IL-17A-positive cells.
(C) IL-17C induced IL-17A expression in Th17 cells over-
expressing IL-17RE but not other IL-17R family members.
CD4+ T cells were retrovirally transduced with each
IL-17R-IRES-GFP and were cultured with IL-17C in Th17
cell polarizing condition. Cells were restimulated with PMA
and ionomycin and GFP-positive cells were gated to show
expression of IL-17A and IFN-g.
(D) Intracellular cytokine staining of WT and Il17ra/
T cells retrovirally transduced with IL-17RE and cultured
with IL-17C for 2 days, followed by 5 hr of PMA and ion-
omycin. Data shown are gated GFP+ cells. Data shown are
representative of at least three experiments.
(E) Coimmunoprecipitation of IL-17RA with HA-tagged
IL-17RE. 293T cells were transfected with IL-17RA or
HA-tagged IL-17RE or both and immunoprecipitated with
anti-HA.
(F) Intracellular cytokine staining of WT and Act1/ T cells
retrovirally transduced with IL-17RE or control viral vector
(RV-GFP) and followed by 5 hr of PMA and ionomycin.
Data shown are gated GFP+ cells. Data shown are repre-
sentative of at least three experiments.
See also Figure S4.
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IL-17F, and IL-25). The IL-17R family has also been extended
to five members (IL-17RA, IL-17RB, IL-17RC, IL-17RD, and IL-
17RE). The IL-17 cytokine family is evolutionally conserved.
The S. purpuratus genome sequence contains 30 IL-17-like
genes as the most diverse gene family among cytokines and
growth factors (Hibino et al., 2006). Therefore, elucidating the
biological roles and regulation of IL-17 and IL-17R family
members are critical to understand inflammatory responses
in host defense against infections and in autoimmunity. The
least-understood members of IL-17 cytokine family are IL-17B,
IL-17C, and IL-17D. Although some in vitro analyses indicate
that they may promote inflammation, genetic approaches are
needed to provide a better answer to the biological function of
molecules.
Il17c/ mice developed normally but were found to be resis-
tant to EAE, indicating its role as a proinflammatory cytokine. To
understand which cells are the targets of IL-17C and how IL-17C
functions in vivo to promote inflammation, we searched for its
receptor and identified IL-17RE as its receptor. IL-17RE is616 Immunity 35, 611–621, October 28, 2011 ª2011 Elsevier Inc.induced in a subset of differentiated CD4+
T cells, Th17 cells. mRNA of a shorter isoform
lacking the transmembrane domain of IL-17RE
was also detected in other types of CD4+
T cells as well as other, non-CD4+ cell types. It
is unknown at this stage whether the shorter
isoform is secreted because of a lack of trans-
membrane domain or whether it has any biolog-
ical function.We show that IL-17C promotes the development of Th17
cells. Intriguingly, IL-17RE partners with IL-17RA to be an effec-
tive signaling receptor for IL-17C. IL-17RA interacts with
IL-17RC to provide signaling for IL-17A and IL-17F to promote
tissue inflammation, mostly by nonhematopoietic cells such as
fibroblasts and epithelial cells. Whereas IL-17RA is expressed
universally, the role of IL-17RA in hematopoietic cells is less
understood. We recently reported that IL-17RA interacts with
IL-17RB in CD4+ T cells and that the IL-17RA-IL-17RB signaling
pathway is essential in the induction of Th2 and Th9 cells in
response to IL-25 (Angkasekwinai et al., 2010). Our current
study shows that another IL-17 receptor family, IL-17RE, can
interact with IL-17RA and that this pair is functioning in Th17
cells. Additionally, we report here that Act1, a membrane-prox-
imal adaptor molecule, is required for IL-17C signaling. Activa-
tion of the IL-17RA-RE and Act1 complex by IL-17C leads to
induction of IkBz. IkBz was recently reported to be a positive
regulator of Th17 cells and is indispensable for the develop-
ment of EAE. IkBz expression can be induced upon the activa-
tion of IL-17RA in fibroblasts or epithelial cells in response to
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Figure 5. IL-17C-IL-17RE Regulates IkBz Expression
(A) ELISA of cytokine production in CD4+ T cells retrovirally
transduced with IL-17RE or control viral vector and treated
with IL-17C for 2 days in Th17 cell condition. Sorted GFP+
cells were activated with anti-CD3 for 24 hr.
(B) Real-time RT-PCR analysis of cytokine and transcription
factor expression in CD4+ T cells retrovirally transduced and
cultured either in neutral or Th17 cell conditions. The cells
were activated with anti-CD3 for 4 hr for cytokine mRNA
detection.
(C) Real-time RT-PCR analysis of Nfkbiz prepared as above.
*p < 0.05 (Student’s t test).
(D) Real-time RT-PCR analysis of cytokine and transcription
factor in CD4+ T cells retrovirally transduced with hCD2-IkBz
or control viral vector (PMIG- hCD2). Sorted hCD2+ cells
were activated with anti-CD3 for 4 hr.
(E) Intracellular IL-17A and IFN-g staining in CD4+ T cells
retrovirally transduced with IkBz or control viral vector and
cultured in Th17 cell condition.
Data shown are representative of at least three independent
experiments.
See also Figure S5.
Immunity
IL-17C and IL-17RE in Th17 Cell RegulationIL-17A and IL-17F. Although the signaling mechanisms of IL-
17C-IL-17RE are yet to be determined in detail, overlap of
the IL-17C signaling pathway with other IL-17 cytokine family
members may exist because they share a common receptor,
IL-17RA. IL-25, on the other hand, utilizes IL-17RA-IL-17RB
and Act1 but does not induce IkBz in differentiated Th2 cells
(data not shown).
Although we showed that IL-17C is necessary for EAE, we
did not find any effect on Th17 cell generation in Il17c/
mice. IL-17C does not directly regulate Th1 cell differentiation
or function, as shown by the fact that IL-17RE is not upregu-
lated during Th1 cell differentiation and IL-17C did not have
any effect on Th1 cell differentiation, even when IL-17RE was
overexpressed in these cells. In contrast, IL-17RE is upregu-
lated in Th17 cells after their differentiation. These data suggest
a model whereby IL-17C-IL-17RE regulates effector Th17 cell
function in the inflamed tissues. This model is supported by
our following results: (1) IL-17C is upregulated in CNS but notImmunity 35, 6in spleen during EAE; (2) IL-17RE is not ex-
pressed by naive T cells but upregulated in
effector Th17 cells; (3) effector Th17 but not
naive T cells respond to IL-17C by upregulating
IL-17A and IL-17F production; and (4) Th17 cyto-
kine and downstream chemokine production
was inhibited in CNS of EAE mice. All these
results support a direct regulation of IL-17C on
effector Th17 cells. However, it is possible that
there are additional cell types regulated by IL-
17C in EAE. Additional experiments via selective
ablation of IL-17RE will conclusively resolve this
issue.
The expression, regulation, and role of IL-17C
and IL-17RE in the immune system deserve
further exploration. Nonetheless, our study has
provided insight into the physiological role of IL-
17C in autoimmune disease, owing, at least inpart, to its ability in promote Th17 cell development by interact-
ing with its receptor, IL-17RE.
EXPERIMENTAL PROCEDURES
Induction of EAE
C57BL/6 mice were purchased from Jackson Laboratories. Mice were housed
in the specific-pathogen-free (SPF) animal facility at M.D. Anderson Cancer
Center, and the animal experiments were performed at the age of 6–10 weeks
with protocols approved by the Institutional Animal Care and Use Committee.
EAE disease was induced with MOG35-55/CFA as previously described (Rey-
nolds et al., 2010). Clinical scores were as follows: 0, no disease; 1, tail paral-
ysis; 2, wobbly gait; 3, hind limb paralysis; 4, forelimb paralysis; 5, moribund or
dead. 0.5 gradations were assigned to animals exhibiting symptoms falling
between two of the above listed scores.
CNS mRNA Analysis
A section of brain and spinal cord was taken from the same location of each
mouse after perfusion on day 14 after EAE induction. Tissues were homoge-
nized and mRNA was isolated with Trizol reagent (Invitrogen). cDNA was11–621, October 28, 2011 ª2011 Elsevier Inc. 617
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Figure 6. CD4-IL-17RE Transgenic Mice Develop
Exacerbated EAE Symptoms and Enhanced IkBz
Expression in CNS
(A) Real-time RT-PCR analysis of Il17remRNA expression
in naive T cells isolated from WT or different lines of
transgenic mice.
(B) Frequency of IL-17A- and IFN-g-producing cells in
naive T cells isolated from WT or CD4-IL-17RE (TG) mice
and activatedwith anti-CD3, anti-CD28, TGF-b, and IL-6 in
the presence or absence of IL-17C for 4 days, followed by
5 hr of PMA and ionomycin stimulation in the presence of
protein transport inhibitor (BD GolgiStop).
(C) EAE was induced in WT and TG animals. Data repre-
sent the mean ± SD of n = 11 (WT) and n = 12 (TG) from
three independent experiments.
(D) Total number of mononuclear cells recovered
from CNS.
(E) Real-time RT-PCR analysis of Nfkbiz mRNA expres-
sion. Data represent the mean ± SD from two independent
experiments. *p < 0.05 (Student’s t test).
(F) ELISA of cytokine production from splenocytes
expanded with MOG35-55 peptide for 3 days. All compar-
isons presented were statistically significant (p < 0.05).
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duplicate samples via previously described primers with b-actin as a reference
gene (Reynolds et al., 2010).
Retroviral Transduction and Th Cell Differentiation
pGFP-RV-IL-17RE (GenBank accession number NM_145826) was generated.
The plasmid pGFP-RV contains an internal ribosomal entry site (IRES)-
regulated green fluorescent protein gene (IRES-GFP). Naive CD4+CD25
CD44loCD62Lhi T cells from C57BL/6 mice, Il17ra/ (provided by Amgen),
Act1/ mice were sorted by flow cytometry and activated with plate-bound
anti-CD3 (0.5 mg/ml; 2C11; BioXcell) plus soluble anti-CD28 (0.5 mg/ml;
37.51, BioXcell) in the presence of anti-IFN-g (XMG 1.2 [BE0055], BioXcell)
and 10 mg/ml anti-IL-4 (11B11 [BE0045]; BioXcell). 36 hr after activation, cells
were spin-infected with retrovirus expressing IL-17RE or control empty vector.
After 4 hr of infection, medium was replaced with and without IL-17C either in
neutral condition with anti-IL-4 and anti-IFN-g or Th17 cell condition medium
(10 ng/ml IL-6 [216-16; Peprotech], 2 ng/ml TGF-b). Also, different IL-17 family
cytokines (IL-17A, IL-17B, IL-17D, IL-17F [R&D]) were added to culture after
retroviral infection. For IkBz overexpression, Nfkbiz (GenBank accession618 Immunity 35, 611–621, October 28, 2011 ª2011 Elsevier Inc.number NM_030612) was cloned into retroviral vector,
hCD2-pMIGR2. Two days after infection, GFP+ or hCD2+
cells were sorted by flow cytometry and restimulated
with plate-bound anti-CD3 (1 mg/ml) for 4 hr, and cells
were then collected for RNA extraction. For cytokine
measurement by ELISA, culture supernatants were
collected at 24 hr. For intracellular cytokine analysis, cells
were restimulated with 500 ng/ml of ionomycin and
50 ng/ml of PMA in the presence of Golgi Stop (BD Phar-
Mingen) for 5 hr. Cells were then permeabilized with Cyto-
fix/Cytoperm Kit (BD PharMingen) and analyzed for the
expression of IL-17A or IFN-g (BD PharMingen). Th cell
differentiation to Th1, Th2, and iTreg cells was described
previously (Yang et al., 2008c).
Expression of IL-17C-Ig Protein and Binding
to IL-17RE
IL-17C-hIg protein was generated by PCR amplification of
a sequence coding aa 15–194 (GenBank accession
number NM_145834), then cloned into the DES-Ig vector.
IL-17C-hIg expression vector was stably transfected into
Drosophila S2 cells, and the secreted IL-17C-hIg fusionprotein was purified with a protein A column. For detection of IL-17RE binding,
293 cells were transfected with full length of IL-17RE or empty vector (pcDNA).
IL-17C-hIg fusion protein or control human IgG1 was added to the transfected
293 cells, followed by anti-human Ig conjugated with APC. Before staining,
cells were preblocked with human IgG1 (Sigma-Aldrich).
Immunoprecipitation
293T cells expressing HA-IL-17RE and/or IL-17RA were washed once with
ice-cold PBS and lysed in lysis buffer. Lysates were used for immunoblot or
immunoprecipitation. For immunoprecipitation, cleared cell lysates were incu-
bated with HA antibody for 120 min, followed by four washes in lysis buffer.
Immunoprecipitates were denatured with 2 3 SDS sample buffer before
SDS-PAGE. Protein transfer was followed by overnight incubation with anti-
HA or anti-IL-17RA (R&D). After incubation with HRP-conjugated secondary
antibody, the signal was detected with ECL reagent (Promega).
RT-PCR Analysis
Total RNA extracted by Trizol reagent (Invitrogen) was used to generate
cDNA via oligo(dT), random hexamers, and MMLV reverse transcriptase
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Figure 7. IL-17C-IL-17RE Enhanced Polarized
Th17 Cell Response
(A) Representative flow cytometry plot of Th17 cells
from IL-17FRFP mice polarized with TGF-b and IL-6 at
day 5.
(B) ELISA of IL-17A production in polarized Th17 cells with
or without IL-17C in the presence of increasing concen-
tration of aCD3.
(C) ELISA of cytokine production in polarized Th17 cells
cultured with irradiated splenocytes in the presence of
increasing concentration of IL-17C.
(D) Real-time RT-PCR analysis of Il17c in CNS and spleen
from normal and EAE mice.
All comparisons presented were statistically significant
(***p < 0.001, **p < 0.01, *p < 0.05).
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SYRB Green Supermix (Bio-Rad Laboratories). The data were normalized to
actin as a reference gene. The primer pairs for real-time RT-PCR analysis of
Il17a, IL17f, IL-22, Rora, Rorc, Il23r, and Nfkbiz (Shen et al., 2005; Yang et al.,
2008c) were previously described. Primer pair for detection of Il17re is
(forward) 50-CAGTCCCAGTGACGCTAGAC-30 and (reverse) 50-ACCCACTA
GAGCGGTGAGAG-30. Primer pair for RT-PCR analysis to detect full-length
Il17re and Il17re lacking transmembrane domain is (forward) 50-ATGTCC
ATTTTGCCTGGAAG-30 and (reverse) 50-CTACAGACAGCTGAAACCACA-30.
Primer pair for detection of Il17c is (forward) 50-GCTCCTCCACACCTGC
TAAC-30 and (reverse) 50-CTGTGGGTAGCGGTTCTCAT-30.
Generation of CD4-IL-17RE Transgenic Mice
A cDNA encoding full-length mouse IL-17RE was cloned into SalI site of the
CD4 minigene plasmid, which contains CD4 promoter/enhancer and the first
intron without the silencer element (a gift from D. Littman). The IL-17RE trans-
gene construct was digestedwith NotI andmicroinjected into C57BL/6mice at
the Transgenic Mouse Facility at MD Anderson Cancer Center. Subsequent
screening of CD4-IL-17RE transgenic mice was carried out by genomic PCR
with the following primers: forward, 50-GCCTTGGCCTCCTAGCTACT-30;
reverse, 50- CTTCCTCTGGAAGGATGCTG-30.
Generation of Il17c Gene-Targeted Mice
Il17c/ mice were generated by introducing a LacZ reporter cassette into
the Il17c locus in the 129/TC1 embryonic stem cell line. The targeting vector
contained puromycin as a positive selection marker and the diphtheria toxin
A gene as a negative selection marker. Targeted ES clones were selected
and injected into C57BL/6 blastocysts to generate chimeras. High-percentage
chimeras were bred with female CMV-Cre transgenic mice to obtain Il17c+/
mice. Heterozygous mice were then bred to obtain homozygous knockout
mice and WT littermates for experiments. The genotyping primers for
Il17c/ mice were as follows: forward, 50-GCCTATTTGCCCACCTACAA-30;
reverse 1, 50-AGTGTCAGCTTCCAGCACCT-30; reverse 2, 50-AAATTCAGAC
GGCAAACGAC-30. The forward primer and the reverse 1 primer amplify
a 410 bp WT band, whereas the forward and reverse 2 primers (located in
the LacZ region) give a 650 bp knockout band.Immunity 35, 61Act1 Gene-Targeted Mice
A new Act1/ mouse generated by gene trap mutagen-
esis was obtained from Texas Institute for Genomic
Medicine. Mouse genomic sequence surrounding the
gene trap insertion site identified in the C57BL/6
gene trap ES cell clone IST11484G7 was Traf3ip2. The
genotyping primers for Act1/ mice were as follows:
forward 1, 50-TGCTCACCTGGAATATGCTG-30; reverse
1, 50-TTGTTTGGTGGGGGTACAGT-30; reverse 2, 50-CC
AATAAACCCTCTTGCAGTTGC-30. The forward 1 and
reverse 1 primers, surrounding LTR region of gene trap
vector, amplify a 485 bp WT band, whereas the forward1 and reverse 2 primers, flanking the deleted exons, give a 300 bp knockout
band.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and can be found with this
article online at doi:10.1016/j.immuni.2011.09.010.
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